STW:PA:PA-SPDR® MSCI Europe Health Care UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 229.5

Change

+1.65 (+0.72)%

Market Cap

USD 0.79B

Volume

259.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-07 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

+0.02 (+0.04%)

USD 64.41B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

+1.70 (+0.33%)

USD 12.63B
WRD:PA HSBC ETFs Public Limited Compa..

+0.12 (+0.34%)

USD 10.26B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

+0.55 (+0.23%)

USD 8.94B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

+1.50 (+0.34%)

USD 7.98B
HHH:PA HSBC ETFs Public Limited Compa..

+0.18 (+0.34%)

USD 7.03B
WLD:PA Lyxor UCITS MSCI World D-EUR

+0.93 (+0.28%)

USD 6.87B
LCWD:PA Multi Units Luxembourg - Lyxor..

+0.05 (+0.27%)

USD 6.47B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

+1.45 (+0.39%)

USD 5.17B
S500:PA Amundi S&P 500 ESG UCITS ETF A..

+0.72 (+0.48%)

USD 4.78B

ETFs Containing STW:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 14.32% 65% D 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.32% 65% D 73% C
Trailing 12 Months  
Capital Gain 14.15% 33% F 56% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.15% 33% F 56% F
Trailing 5 Years  
Capital Gain 59.24% 68% D+ 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 59.24% 68% D+ 77% C+
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 0.79B 78% C+ 78% C+

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:

There is nothing we particularly dislike